NSCLC, metastatic CheckMate 026: A phase 3 trial of nivolumab vs investigator's choice (IC) of platinum-based doublet chemotherapy (PT-DC) as first-line therapy for stage iv/recurrent programmed death ligand 1 (PD-L1)−positive NSCLC
Socinski, M., Creelan, B., Horn, L., Reck, M., Paz-Ares, L., Steins, M., Felip, E., van den Heuvel, M., Ciuleanu, T.E., Badin, F., Ready, N., Hiltermann, T.J.N., Nair, S., Juergens, R., Peters, S., Minenza, E., Geese, W.J., Bhagavatheeswaran, P., Chen, A., Carbone, D.P.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
EGFR, pMAPK, pAkt and PTEN status by immunohistochemistry: correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab
Gori, S., Sidoni, A., Colozza, M., Ferri, I., Mameli, M. G., Fenocchio, D., Stocchi, L., Foglietta, J., Ludovini, V., Minenza, E., De Angelis, V., Crinò, L.
Published in Annals of oncology (01.04.2009)
Published in Annals of oncology (01.04.2009)
Get full text
Journal Article
Phase II Study of Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer
Ramalingam, S.S, Mazières, J, Planchard, D, Stinchcombe, T.E, Dy, G.K, Antonia, S.J, Horn, L, Lena, H, Minenza, E, Mennecier, B, Otterson, G.A, Campos, L.T, Gandara, D.R, Levy, B.P, Nair, S.G, Zalcman, G, Wolf, J, Baudelet, C, Lestini, B.J, Rizvi, N.A
Published in International journal of radiation oncology, biology, physics (01.12.2014)
Published in International journal of radiation oncology, biology, physics (01.12.2014)
Get full text
Journal Article
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
Hellmann, Matthew D, Ciuleanu, Tudor-Eliade, Pluzanski, Adam, Lee, Jong Seok, Otterson, Gregory A, Audigier-Valette, Clarisse, Minenza, Elisa, Linardou, Helena, Burgers, Sjaak, Salman, Pamela, Borghaei, Hossein, Ramalingam, Suresh S, Brahmer, Julie, Reck, Martin, O’Byrne, Kenneth J, Geese, William J, Green, George, Chang, Han, Szustakowski, Joseph, Bhagavatheeswaran, Prabhu, Healey, Diane, Fu, Yali, Nathan, Faith, Paz-Ares, Luis
Published in The New England journal of medicine (31.05.2018)
Published in The New England journal of medicine (31.05.2018)
Get full text
Journal Article
First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
Carbone, David P, Reck, Martin, Paz-Ares, Luis, Creelan, Benjamin, Horn, Leora, Steins, Martin, Felip, Enriqueta, van den Heuvel, Michel M, Ciuleanu, Tudor-Eliade, Badin, Firas, Ready, Neal, Hiltermann, T. Jeroen N, Nair, Suresh, Juergens, Rosalyn, Peters, Solange, Minenza, Elisa, Wrangle, John M, Rodriguez-Abreu, Delvys, Borghaei, Hossein, Blumenschein, George R, Villaruz, Liza C, Havel, Libor, Krejci, Jana, Corral Jaime, Jesus, Chang, Han, Geese, William J, Bhagavatheeswaran, Prabhu, Chen, Allen C, Socinski, Mark A
Published in The New England journal of medicine (22.06.2017)
Published in The New England journal of medicine (22.06.2017)
Get full text
Journal Article
5089 Shorter Overall Survival (OS) in HER2-positive (HER2+) metastatic breast cancer (MBC) patients (pts) treated with trastuzumab (T)± chemotherapy (CT) and overexpressing HER3 by immunohistochemistry (IHC)
Gori, S, Sidoni, A, Colozza, M, Mameli, M.G, Fenocchio, D, Minenza, E, Foglietta, J, Stocchi, L, De Angelis, V, Crinò, L
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
TP53 mutations predicts worse prognosis in EGFR-mutated NSCLC patients receiving TKIs in first- or further line of treatment
Canale, M., De Luigi, N., Petracci, E., Delmonte, A., Ludovini, V., Dubini, A., Baglivo, S., Minenza, E., Chiadini, E., Landi, L., Papi, M., Bronte, G., Crinò, L., Ulivi, P.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1534PTP53 mutations predicts worse prognosis in EGFR-mutated NSCLC patients receiving TKIs in first- or further line of treatment
Canale, M, Luigi, N De, Petracci, E, Delmonte, A, Ludovini, V, Dubini, A, Baglivo, S, Minenza, E, Chiadini, E, Landi, L, Papi, M, Bronte, G, Crinò, L, Ulivi, P
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1534P - TP53 mutations predicts worse prognosis in EGFR-mutated NSCLC patients receiving TKIs in first- or further line of treatment
Canale, M., De Luigi, N., Petracci, E., Delmonte, A., Ludovini, V., Dubini, A., Baglivo, S., Minenza, E., Chiadini, E., Landi, L., Papi, M., Bronte, G., Crinò, L., Ulivi, P.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
P1.14-05 TP53 Exon 8 Mutation and Prognosis in EGFR-Mutated NSCLC Patients Treated with First-And-Second-Generation TKIs
Canale, M., Petracci, E., Crino, L., De Luigi, N., Ludovini, V., Dubini, A., Baglivo, S., Minenza, E., Chiadini, E., Landi, L., Papi, M., Delmonte, A., Bronte, G., Ulivi, P.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
Phase 2 Study of Nivolumab (ANTI-PROGRAMMED DEATH-1 [PD-1]) in Patients (PTS) with Advanced, Refractory Squamous (SQ) Non-Small Cell Lung Cancer (NSCLC)
Zalcman, G., Rizvi, N.A., Lena, H., Wolf, J., Mazieres, J., Antonia, S.J., Minenza, E., Planchard, D., Lestini, B.J., Ramalingam, S.S.
Published in Annals of oncology (01.04.2015)
Published in Annals of oncology (01.04.2015)
Get full text
Journal Article
P1.01-053 Italian Nivolumab Expanded Access Programme (EAP): Data from Patients with Advanced Non-Squamous NSCLC and Brain Metastases
Crinò, L., Bidoli, P., Ulivi, P., Minenza, E., Cortesi, E., Garassino, M., Cappuzzo, F., Grossi, F., Tonini, G., Sarobba, M.G., Pinotti, G., Numico, G., Samaritani, R., Ciuffreda, L., Frassoldati, A., Bregni, M.B., Santo, A., Piantedosi, F., Illiano, A., De Marinis, F., Delmonte, A.
Published in Journal of thoracic oncology (01.11.2017)
Published in Journal of thoracic oncology (01.11.2017)
Get full text
Journal Article
Phase II Study of Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer: Metastatic Non-small Cell Lung Cancer
Ramalingam, S.S., Mazières, J., Planchard, D., Stinchcombe, T.E., Dy, G.K., Antonia, S.J., Horn, L., Lena, H., Minenza, E., Mennecier, B., Otterson, G.A., Campos, L.T., Gandara, D.R., Levy, B.P., Nair, S.G., Zalcman, G., Wolf, J., Baudelet, C., Lestini, B.J., Rizvi, N.A.
Published in International journal of radiation oncology, biology, physics (01.12.2014)
Published in International journal of radiation oncology, biology, physics (01.12.2014)
Get full text
Journal Article
HER2, EGFR, PIK3CA mutations in HER2+ metastatic breast cancer (MBC) patients (pts) treated with trastuzumab (T): Incidence and correlation with response
Gori, S., Ludovini, V., Colozza, M., Pistola, L., Tofanetti, F. R., Flacco, A., Foglietta, J., Minenza, E., Stocchi, L., De Angelis, V., Crinò, L.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article